Astellas Pharma: Revision of full-year earnings forecasts with recorded fair value fluctuations relating to conditional compensation for impairment losses of intangible assets

JPX · Apr 12 15:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.